Milestone Pharmaceuticals Inc. — Form D

Milestone Pharmaceuticals Inc. of MONTREAL, A8, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-25. The offering totals $6.9M, of which $6.9M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Dion G MadsenDirectorMontreal, A8
Yves G RosconiDirectorMontreal, A8
Scott G WeinerDirectorMontreal, A8
Martin G MaguireExecutive OfficerMontreal, A8
Scott WeinerDirectorNew York, NY
Guy G RousseauExecutive OfficerMontreal, A8
Nilesh G KumarDirectorMontreal, A8
Debra G LiebertDirectorMontreal, A8
Paul G TruexDirectorMontreal, A8
Francis G PlatExecutive OfficerMontreal, A8
Joseph G OlivetoDirectorMontreal, A8
Joseph G OlivetoExecutive OfficerMontreal, A8
Douglas G WightExecutive OfficerMontreal, A8
Philippe G DouvilleExecutive OfficerMontreal, A8
Marco G BoorsmaDirectorMontreal, A8
Harish G PimplaskarExecutive OfficerMontreal, A8
Lorenz G MullerExecutive OfficerMontreal, A8
Jeff G NelsonExecutive OfficerMontreal, A8
Eric LinsleyDirectorDurham, NC
Debra LiebertDirectorMontreal, A8
Ela BorensteinDirectorMontreal, A8
Francis PlatExecutive OfficerMontreal, A8
Yves RosconiDirectorMontreal, A8
Martin MaguireExecutive OfficerMontreal, A8
Philippe DouvilleDirectorMontreal, A8

Other filings by this issuer (3)

FiledFormOfferingSold
2018-10-26D$80.0M$80.0M
2015-06-15D$9.4M$3.8M
2011-06-14D$596K$596K

More